Baheal Zhongxin Capital
Overview
Baheal Zhongxin Capital is a healthcare-focused investment firm that serves as the innovation incubation and investment management arm of the Baheal Pharma Group, specializing in early-stage investments in innovative drugs, high-end medical devices, and basic research platforms.
Portfolio Companies
1
Website
bahealcap.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Maxinovel Pharmaceuticals | Oct 2022 | Series C Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Baheal Zhongxin Capital based?
Baheal Zhongxin Capital is headquartered in Beijing, China.
When was Baheal Zhongxin Capital founded?
Founding year information for Baheal Zhongxin Capital is not publicly available.
How many portfolio companies does Baheal Zhongxin Capital have?
Baheal Zhongxin Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Baheal Zhongxin Capital's portfolio?
Recent investments visible on Caplight include Maxinovel Pharmaceuticals.
What was Baheal Zhongxin Capital's most recent investment?
Baheal Zhongxin Capital's most recent investment on Caplight was in Maxinovel Pharmaceuticals in 2022.
What sectors does Baheal Zhongxin Capital focus on?
Baheal Zhongxin Capital focuses on Healthcare & Life Sciences.
What company stages does Baheal Zhongxin Capital focus on?
Baheal Zhongxin Capital typically invests at the Mid stage.